Recipient sex |
0.604 |
n.a. |
n.a. |
Recipient blood group |
0.562 |
n.a. |
n.a. |
Age in years at last transplantation |
0.433 |
n.a. |
n.a. |
Number of kidney transplants |
0.653 |
n.a. |
n.a. |
PRA max. in % |
0.460 |
n.a. |
n.a. |
PRA max. in groups (0–30%, >30–70%, and >70%) |
0.480 |
n.a. |
n.a. |
PRA at last transplant in % |
0.412 |
n.a. |
n.a. |
PRA at last transplant in groups (0–30%, >30–70%, and >70%) |
0.427 |
n.a. |
n.a. |
Number of HLA-DR mismatches |
0.441 |
n.a. |
n.a. |
Number of all HLA mismatches |
0.004 |
1.657 |
1.180–2.326 |
Number of all HLA mismatches in groups (0–2, 3–6) |
0.002 |
4.440 |
1.691–11.655 |
Plasmapheresis (yes/no) |
0.410 |
n.a. |
n.a. |
Induction therapy (yes/no) |
0.334 |
n.a. |
n.a. |
Type of induction therapy |
0.261 |
n.a. |
n.a. |
Cyclosporine versus tacrolimus based therapy |
0.028 |
3.176 |
1.131–8.916 |
Mycophenolate mofetil versus azathioprine therapy |
0.839 |
n.a. |
n.a. |
Living donor versus deceased donor |
0.374 |
n.a. |
n.a. |
Simultaneous nephrectomy of previous graft (yes/no) |
0.535 |
n.a. |
n.a. |
Number of previous operations at transplant site |
0.463 |
n.a. |
n.a. |
Operating time in minutes |
0.958 |
n.a. |
n.a. |
Cold ischemic time in minutes |
0.914 |
n.a. |
n.a. |
Surgical complications (yes/no) |
0.059 |
n.a. |
n.a. |
Number of surgical complications |
0.003 |
2.225 |
1.318–3.758 |
Reoperation due to a complication (yes/no) |
0.026 |
3.013 |
1.144–7.939 |
Primary graft nonfunction (yes/no) |
<0.001 |
6.384 |
2.290–17.797 |
Acute graft rejection episodes (yes/no) |
0.005 |
4.872 |
1.602–14.816 |
Chronic graft rejection (yes/no) |
0.888 |
n.a. |
n.a. |